¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • atrophy
    À§Ãà(Áõ)
  • alveolar atrophy
    ÀÌÆ²À§Ãà, Ä¡Á¶À§Ãà
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀåÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà, ÇÇÁúÀ§Ãà
  • choroidal atrophy
    ¸Æ¶ô¸·À§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    Áöµµ¸ð¾çÀ§Ãà
  • geographic retinal atrophy
    Áöµµ¸ð¾ç¸Á¸·À§Ãà
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà
  • cyanotic atrophy
    û»öÁõÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    ÁöµµÇüÀ§Ãà
  • halisteretic atrophy
    ŻȸÀ§Ãà
  • lactation atrophy
    ¼öÀ¯À§Ãà, Á¥ºÐºñÀ§Ãà
  • macular atrophy
    (¢¡anetoderma) ÇǺÎÀ§ÃàÁõ
  • mast atrophy
    À¯¹æÀ§Ãà
  • muscular atrophy
    ±ÙÀ°À§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • geographic atrophy
    ÁöµµÇüÀ§Ãà
  • gingival atrophy
    Ä¡ÀºÀ§Ãà(öÍó»ê×õê).
  • glaucomatous optic nerve atrophy
    ³ì³»Àå½Ã½Å°æÀ§Ãà.
  • granular atrophy of kidney
    ½ÅÀå°ú¸³¼ºÀ§Ãà.
  • gray optic atrophy
    ȸ»ö½Ã½Å°æÀ§Ãà
  • halisteretic atrophy
    Żȸ¼º À§Ãà(÷­üéàõê×õê).
  • hemilingual atrophy
    ÆíÃø¼³À§Ãà
  • hereditary optic atrophy
    À¯Àü¼º½Ã½Å°æÀ§Ãà.
  • hereditary optic atrophy
    À¯Àü¼º ½Ã½Å°æÀ§Ãà.
  • hypothenar atrophy
    ¼ÒÁö±¸À§Ãà.
  • hypothenar atrophy
    ¼ÒÁö±¸ À§Ãà(á³ò¦Ï¹êÍõê).
  • infantile muscular atrophy =Werdnig-Hoffmann disease
    ¿µ¾ÆÇü±ÙÀ§ÃàÁõ(?ä®û¡ÐÉê×õêñø).
  • infantile muscular atrophy =Werdnig-Hoffmann disease
    ¿µ¾ÆÇü ±ÙÀ§ÃàÁõ(?ä®û¡ÐÉê×õêñø).
  • infantile progressive spinal muscular atrophy
    ¿µ¾ÆÁøÇ༺ ô¼ö¼º ±ÙÀ§Ãà(Áõ).
  • peroneal muscular atrophy
    ºñ°ñ±Ù À§ÃàÁõ(ÝëÍéÐÉê×õêñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fatty exudate
    Áö¹æ»ïÃâ¹°, °æ¼º»ïÃâ¹°
  • fatty food intolerance
    Áö¹æ½ÄºÒ³»¼º(¡­ãÝÝÕÒ±àõ).
  • fatty ingrowth
    Áö¹æ ħÀ±(¡­öÙëÈ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ).
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • fatty oil
    Áö¹æÀ¯(̤ËÑËô).
  • fatty stool
    Áö¹æº¯(ò·Û¸øµ).
  • fatty streak
    Áö¹æ ¼±Á¶
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • non-esterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê
  • nonesterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê(Þª~ûùò·Û¸ß«).
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê(øöñÞò·Û¸ß«).
  • omega-3 fatty acid
    ¿À¸Þ°¡-3 Áö¹æ»ê(¡­ò·Û¸ß«)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fatty infiltration
    Áö¹æÄ§À±(ò·Û¸öÕëÈ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • free fatty acids
    À¯¸® Áö¹æ»ê(ë´×îò·Û¸ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
  • long-chain fatty acid thiokinase
    ±ä»ç½½Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • medium-chain fatty acid thiokinase
    Áß(ñé)»ç½½ Áö¹æ»ê(ò·Û¸ß«) Ä¡¿ÀÄ«À̳×À̽º
  • monoenoic fatty acid
    ÀÏ(ìé)¿£ Áö¹æ»ê(ò·Û¸ß«)
  • odd-numbered fatty acid
    Ȧ¼ö Áö¹æ»ê(ò·Û¸ß«)
  • polyenoic fatty acid
    Æú¸®¿¡³ëÀÎ Áö¹æ»ê(ò·Û¸ß«)
  • polyunsaturated fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê(ÒýÝÕøéûúò·Û¸ß«)
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê(øéûùò·Û¸ß«)
  • unsaturated fatty acid
    ºÒÆ÷È­(ÝÕøéûú) Áö¹æ»ê(ò·Û¸ß«)
  • very long-chain fatty acids
    ¸Å¿ì ±ä »ç½½ Áö¹æ»ê(ò·Û¸ß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • thenar atrophy
    ¹«Áö±¸À§Ãà
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DIDMOA diabetes insipidus-diabetes mellitus-optic atrophy [syndrome]
DIDMOAD diabetis insipidus, diabetes mellitus, otpic atrophy, deafness [syndrome]
DIMOAD diabetes insipidus, diabetes mellitus, optic atrophy, deafness
DJOA dominant juvenile optic atrophy
DMOA diabetes mellitus-optic atrophy [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GA Gyrate atrophy
HCSMA Hereditary Canine Spinal Muscular Atrophy
HA Hippocampal atrophy
MSA Multiple System Atrophy
OPCA Olivo-Ponto-Cerebellar Atrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subcutaneous fatty tissue
    ÇÇÇÏ Áö¹æ Á¶Á÷
  • total fatty acids
    ÃÑ Áö¹æ»ê
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­ Áö¹æ»ê
  • age atrophy
    ³ëÀμº ÅðÃà
    ³ªÀ̰¡ µê¿¡ µû¸¥ ¸ðµç Á¶Á÷ÀÇ »ý¸®ÀûÀÎ °¨¼Ò.
  • alveolar atrophy
    Ä¡Á¶ À§Ãà
  • atrophy
    À§Ãà, À§ÃàÁõ, ¹«¿µ¾çÁõ
    ¹Ý´ë¾î=hy
  • atrophy from disuse
    ºñȰµ¿ À§Ãà, ºñȰµ¿¼º À§Ãà, ¹«À§ À§Ãà
    µ¿ÀǾî=disuse atro
  • atrophy noir
    Èæ»ö À§Ãà
  • correlated atrophy
    »ó°ü À§Ãà, »ó°ü À§ÃàÁõ
  • dental atrophy
    Ä¡¾Æ À§Ãà
    Ä¡¾ÆÀÇ ¿ÜÇüÀÌ Á¤»ó »óź¸´Ù ÁÙ¾îµç °Í.
  • dentate cerebellar atrophy
    Ä¡»ó ÇÙ ¼Ò³ú À§Ãà
    ¼Ò³úÀÇ Ä¡»ó ÇÙÀÌ ÁÙ¾îµå´Â º´¼Ò.
  • diffuse atrophy of alveolar bone
    ¹Ì¸¸¼º Ä¡Á¶°ñ À§Ãà
  • disuse muscle atrophy
    ±ÙÆó¿ë À§Ãà
    ±Ù À§ÃàÀº ¿©·¯ °¡ÁöÀÇ ½Å°æ, ±Ù ÁúȯÀÇ ÁÖ¿ä Áõ»óÀ¸·Î¼­ Áß¿äÇѵ¥ ÀÌ¿Í °°Àº Å»½Å°æ¿¡ ÀÇÇÑ ±Ù À§Ãà À̿ܿ¡µµ ¾ÈÁ¤¿Í»óÀ̳ª °üÀý °íÁ¤ µî¿¡ ÀÇÇÑ ºÎµ¿À¸·Î ¹ß»ýÇÏ´Â ±Ù À§ÃàÀÌ ÀÖ°í ÀüÀÚ¿¡ ¸øÁö ¾Ê°Ô Áß¿äÇÏ´Ù. À̰ÍÀ» Æó¿ë¼º ±Ù À§ÃàÀ̶ó°í ÇÑ´Ù. Àå±â¿Í»ó ȯÀÚ¿¡°Ô À־´Â »óÁö¿¡ ºñÇØ¼­ ÇÏÁöÀÇ ±Ù À§ÃàÀÌ µÎµå·¯Áö°í ÀÌ·± °æÇâÀº °í·ÉÀÚ¿¡°Ô ƯÈ÷ ÇöÀúÇÏ´Ù. ü¿ë¼º ±Ù À§ÃàÀÇ ¹ß»ýÀÌ ¿¹»óµÇ´Â °æ¿ì¿¡´Â ¿¹¹æÀ» À§ÇÑ ±Ù·Â À¯Áö Áõ°­ ÈÆ·ÃÀÌ ÀÌ·ç¾îÁ®¾ß ÇÏ°í ¶Ç Á¶±â ÀÌ»ó, Á¶±â º¸ÇàÀÌ ¸ðµç Áúȯ¿¡¼­ ÃßÁøµÉ Çʿ䰡 ÀÖ´Ù.
  • eccentric atrophy
    ¿ø½É¼º À§Ãà
  • facial atrophy
    ¾È¸é À§Ãà
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
unesterified free fatty acid Free fatty acids which occur in plasma as a result of lipolysis in adipose tissue or when plasma triacylglycerols are taken into tissues.
(05 Mar 2000)
fatty Containing fat, or having the qualities of fat; greasy; gross; as, a fatty substance.
<medicine> Fatty acid, a tumour consisting of fatty or adipose tissue; lipoma.
Source: Websters Dictionary
(01 Mar 1998)
fatty acid <biochemistry> Any number of saturated aliphatic monocarboxylic acids. A metabolic byproduct from the breakdown of fats.
Chemically R COOH where R is an aliphatic moiety.
The common fatty acids of biological origin are linear chains with an even number of carbon atoms. Free fatty acids are present in living tissues at low concentrations. The esterified forms are important both as energy storage molecules and structural molecules.
See: triglycerides, phospholipids.
(15 Nov 1997)
fatty acid 2-chloroethyl ester synthase <enzyme> Catalyses the formation of 2-chloroethyl esters of long-chain fatty acids; localised in the microsomal fraction of rat liver
Registry number: EC 2.3.1.-
Synonym: facees, 2-chloroethyl ester synthase
(26 Jun 1999)
fatty-acid amide hydrolase <enzyme> Degrades neuromodulatory fatty-acid amides; genbank u72497
Registry number: EC 3.5.1.-
Synonym: oleamide hydrolase, faah protein, fatty acid amide hydrolase
(26 Jun 1999)
fatty acid binding protein A fatty acid-binding protein that participates in the intracellular movement of fatty acids.
Synonym: fatty acid binding protein.
(05 Mar 2000)
fatty acid binding proteins <biochemistry> Group of small cytosolic proteins that bind fatty acids or other organic solutes.
(18 Nov 1997)
fatty acid desaturases <enzyme> Enzymes that catalyze the conversion of saturated fatty acid CoA complexes to unsaturated fatty acid CoA complexes in the presence of any acceptor.
Registry number: EC 1.14.99.-
(12 Dec 1998)
fatty acid methyltransferase <enzyme> Catalyses the reaction of s-adenosylmethionine and a fatty acid to yield s-adenosylhomocysteine and a fatty acid methyl ester; calcium and calmodulin insensitive
Registry number: EC 2.1.1.15
(26 Jun 1999)
fatty acid oxidation cycle A series of reactions involving acyl-coenzyme A compounds, whereby these undergo beta oxidation and thioclastic cleavage, with the formation of acetyl-coenzyme A; the major pathway of fatty acid catabolism in living tissue.
(05 Mar 2000)
fatty acid reductase <enzyme> Catalyses reduction of fatty acids to aldehydes
Registry number: EC 1.2.1.-
(26 Jun 1999)
fatty acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (fatty acids, unsaturated).
(12 Dec 1998)
fatty acids, essential Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids.
(12 Dec 1998)
fatty acids, monounsaturated Fatty acids which are unsaturated in only one position.
(12 Dec 1998)
fatty acids, nonesterified The fraction of plasma fatty acids that are not in the form of glycerol esters. They are also called free fatty acids, but this is a misnomer because they are transported complexed with albumin.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á